brr interview Tue, 2 Sep 2014 10:30am - Anteo enters into additional agreement, page-54

PSY: "Our LumiMEMS reader provides unparalleled accuracy and sensitivity and has a similar or even lower cost base to anything available in the market today"

It begs the question could it make M&Go largely redundant due to the increased sensitivity?

Because this is totally new generation technology. This is what I'd like biotech to look at but obviously he is elsewhere engaged.

Just based on functionality it seems like ADO and PSY should partner, except for the fact that PSY is at a much earlier stage, and ADO needs funds too, and PSY don't seem to have any funds for the commercialisation stage. So instead of proceeding to market they may have to sell their technology to the highest bidder. Which is often the fate with Australian based technology. They do however have a former Oracle executive who might swing things, but they have been struggling and had to do cutbacks.

(In yet another stroke of genius/shoot your feet policy, the Federal Government has halted Commercialisation Australia activities, which has basically bankrolled ADO's progress to date).

What is frustrating is the ADO SP compared to PSY.

Brickwalls is saying bot control is maybe related to something is hatching with Ferghana. hmmm!